Each technology will fulfill a currently unmet need in cardiovascular medical procedures by improving upon existing technology, or by designing a device to serve a need that is clearly defined and acknowledged by medical professionals.
The Phoenix Cardiac device, called BACE (Basal Annuloplasty of the Cardia Externally), represents a novel modality to treat functional mitral regurgitation because it addresses the root cause of the condition: a heart muscle that is enlarged and weakened. In many cases, the mitral valve itself is structurally normal, but the muscle that supports the valve is weakened and stretched.read more
BACE Device is the only device in development with long term clinical data that has been proven effective in addressing the root cause of Functional Mitral Regurgitation by addressing both annular and sub-annular components of MR while reinforcing the ventricle.read more
Heart valve disease occurs when one or more of the valves in the heart fails to work properly. There are four valves in the heart that open and close with each heartbeat to control the flow of blood during the cardiac cycle.read more
The mitral valve is located at the posterior of the heart. It has two leaflets arranged in the form of bishop’s mitre or cap (hence the name). The mitral valve controls the flow of blood between two chambers of the heart, the left atrium, and the left ventricle.read more
Links to useful resources on Heart Valve Disease and Mitral Regurgitationread more